サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1547697

多血小板血漿の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Platelet Rich Plasma Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 170 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.06円
多血小板血漿の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 170 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

多血小板血漿市場の世界需要は、調査期間2024～2032年のCAGR 11.75%で、2023年の4億3,158万米ドルから2032年には約11億7,297万米ドルの市場規模に達すると推定されます。

多血小板血漿（PRP）は、血液凝固を可能にするタンパク質を含むヒト血液の成分であり、由来する人の治癒を促進することができます。PRPが損傷した組織に注入されると、新しい健康な細胞を成長させるよう身体を刺激し、治癒を促進します。PRPは、患者から血液を採取し、それを2段階の遠心分離にかけ、PRPを赤血球と血小板の少ない血漿に分離することで調製されます。PRP療法は、慢性腱炎、変形性関節症、腱損傷、急性外傷、脱毛症、口腔外科手術、形成外科手術などの患者を治療します。この療法は即効性はないです。

市場力学

痛みがほとんどない、回復が早い、手術の瘢痕組織がないなど、PRP療法のさまざまな利点がこの市場成長の主要原動力となっています。この療法はシンプルであるため、移植の代わりに使用されることがさらに増えると考えられます。スポーツ関連のケガの増加や美容整形手術の採用増加が、この市場の成長を後押しします。PRPは、感染症やアレルギー反応のリスクが全くないため、高齢者の間で非常に人気が高まっています。歯の健康における多血小板血漿治療の効率に関する認識の高まりは、市場を後押しすると考えられます。PRPの唯一の大きな欠点は、肘、筋肉、腱以外の部位の治療に効果がないことです。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、多血小板血漿の世界市場における各セグメントを包括的に評価することもできます。多血小板血漿産業の成長と動向は、この研究に全体的なアプローチを記載しています。

市場セグメンテーション

多血小板血漿市場レポートのこのセクションでは、国と地域レベルのセグメントに関する詳細なデータを提供し、それによって戦略家は、今後の機会で、それぞれの製品やサービスの対象層を特定するのに役立ちます。

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける多血小板血漿市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、本レポートでは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。

カスタムメイドのご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 多血小板血漿-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカー一覧
    • 主要原材料の価格動向
  • 潜在的バイヤー一覧
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 多血小板血漿の世界市場分析：タイプ別

  • タイプ別概要
  • タイプ別過去・予測データ分析
  • 純粋PRP
  • 多白血球PRP
  • 純粋PRF

第6章 多血小板血漿の世界市場分析：由来別

  • 由来別概要
  • 由来別過去・予測データ分析
  • 自己由来
  • 同種異系
  • 同種

第7章 多血小板血漿の世界市場分析：用途別

  • 用途別概要
  • 用途別過去・予測データ分析
  • 整形外科
  • 美容外科
  • 一般外科
  • 脳神経外科
  • その他

第8章 多血小板血漿の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第9章 多血小板血漿企業の競合情勢

  • 多血小板血漿市場の競合
  • 提携/協力/合意
  • 合併・買収
  • 新製品発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Zimmer Biomet Holdings Inc.
  • AdiStem Ltd.
  • ISTO Biologics
  • ThermoGenesis Holdings Inc.
  • Stryker Corporation
  • Exactech Inc.
  • EmCyte Corporation
  • Regen Lab
  • Arthrex Inc.
  • Terumo BCT Inc.（Terumo Corporation）
  • DePuy Synthes Companies（Johnson & Johnson）
  • APEX Biologix LLC
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • Pure-PRP Market Sales By Geography (USD MN)
  • Leukocyte-rich PRP Market Sales By Geography (USD MN)
  • Pure-PRF Market Sales By Geography (USD MN)
  • Analysis By Origin (USD MN)
  • Autologous Market Sales By Geography (USD MN)
  • Allogeneic Market Sales By Geography (USD MN)
  • Homologous Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Orthopedic Surgery Market Sales By Geography (USD MN)
  • Cosmetic Surgery Market Sales By Geography (USD MN)
  • General Surgery Market Sales By Geography (USD MN)
  • Neurosurgery Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Platelet Rich Plasma Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Platelet Rich Plasma Report
  • Market Research Process
  • Market Research Methodology
  • Global Platelet Rich Plasma Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Origin
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • Pure-PRP Market Sales By Geography (USD MN)
  • Leukocyte-rich PRP Market Sales By Geography (USD MN)
  • Pure-PRF Market Sales By Geography (USD MN)
  • Global Market Analysis By Origin (USD MN)
  • Autologous Market Sales By Geography (USD MN)
  • Allogeneic Market Sales By Geography (USD MN)
  • Homologous Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Orthopedic Surgery Market Sales By Geography (USD MN)
  • Cosmetic Surgery Market Sales By Geography (USD MN)
  • General Surgery Market Sales By Geography (USD MN)
  • Neurosurgery Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11213862

The global demand for Platelet Rich Plasma Market is presumed to reach the market size of nearly USD 1172.97 Million by 2032 from USD 431.58 Million in 2023 with a CAGR of 11.75% under the study period 2024-2032.

Platelet-rich plasma, or PRP, is a component of human blood that contains proteins to enable blood clotting and can promote healing in a person it is derived from. When PRP is injected into the damaged tissues, it stimulates the body to grow new, healthy cells and thus promotes healing. PRP is prepared by deriving blood from the person and then passing it through two stages of centrifugation to separate PRP from red blood cells and platelet-poor plasma. PRP therapy treats patients with chronic tendinitis, osteoarthritis, tendon injuries, acute injuries, hair loss conditions, oral surgery, and plastic surgery. This therapy does not provide immediate results.

MARKET DYNAMICS

PRP therapy's various advantages like little or no pain, faster recovery, and no scar tissue over surgery are the key driving force behind this market's growth. The simplicity of this therapy will further propel its use in place of transplants. Rising incidences of sports-related injuries and increased adoption of cosmetic procedures will boost the growth of this market. PRP is becoming very popular among the geriatric community since there is absolutely no risk of infection or allergic reactions involved in the process. Growing awareness about the efficiency of platelet-rich plasma treatment in dental health will be a market booster. PRP's single major drawback is its ineffectiveness in treating areas other than the elbow, muscles, and tendons.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Platelet Rich Plasma. The growth and trends of Platelet Rich Plasma industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Platelet Rich Plasma market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Pure-PRP
  • Leukocyte-rich PRP
  • Pure-PRF

By Origin

  • Autologous
  • Allogeneic
  • Homologous

By Application

  • Orthopedic Surgery
  • Cosmetic Surgery
  • General Surgery
  • Neurosurgery
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Platelet Rich Plasma market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Platelet Rich Plasma market include Zimmer Biomet Holdings Inc., AdiStem Ltd., ISTO Biologics, ThermoGenesis Holdings Inc., Stryker Corporation, Exactech Inc., EmCyte Corporation, Regen Lab, Arthrex Inc., Terumo BCT, Inc. (Terumo Corporation), DePuy Synthes Companies (Johnson & Johnson), APEX Biologix LLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PLATELET RICH PLASMA - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Origin
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PLATELET RICH PLASMA MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. Pure-PRP Historic and Forecast Sales By Regions
  • 5.4. Leukocyte-rich PRP Historic and Forecast Sales By Regions
  • 5.5. Pure-PRF Historic and Forecast Sales By Regions

6. GLOBAL PLATELET RICH PLASMA MARKET ANALYSIS BY ORIGIN

  • 6.1. Overview By Origin
  • 6.2. Historical and Forecast Data Analysis By Origin
  • 6.3. Autologous Historic and Forecast Sales By Regions
  • 6.4. Allogeneic Historic and Forecast Sales By Regions
  • 6.5. Homologous Historic and Forecast Sales By Regions

7. GLOBAL PLATELET RICH PLASMA MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Orthopedic Surgery Historic and Forecast Sales By Regions
  • 7.4. Cosmetic Surgery Historic and Forecast Sales By Regions
  • 7.5. General Surgery Historic and Forecast Sales By Regions
  • 7.6. Neurosurgery Historic and Forecast Sales By Regions
  • 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL PLATELET RICH PLASMA MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PLATELET RICH PLASMA COMPANIES

  • 9.1. Platelet Rich Plasma Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF PLATELET RICH PLASMA INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Zimmer Biomet Holdings Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. AdiStem Ltd.
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. ISTO Biologics
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. ThermoGenesis Holdings Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Stryker Corporation
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Exactech Inc.
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. EmCyte Corporation
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Regen Lab
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Arthrex Inc.
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Terumo BCT Inc. (Terumo Corporation)
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. DePuy Synthes Companies (Johnson & Johnson)
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. APEX Biologix LLC
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies